Data / Form D filings / THERALINK TECHNOLOGIES, INC.
THERALINK TECHNOLOGIES, INC.: Form D filings
THERALINK TECHNOLOGIES, INC., a biotechnology company in Golden, CO, filed 8 Form D notices with the SEC between 2010 and 2022. The latest, on December 14, 2022, reports an offering of $3.4 million with nothing sold yet to 12 investors.
Find out what THERALINK TECHNOLOGIES, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 15000 W. 6TH AVE., #400, Golden, CO, 80401
- Phone
- (888) 585-4923
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Nevada
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(c)
- SEC identifier (CIK)
- 1362703
The full lists. Form D filings in Colorado: 1,787 rows, $89.35, or the new rows each week for $19 a month. Form D filings in Biotechnology: 1,568 rows, $78.40, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, year incorporated, street, city, state and 5 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 14, 2022 | New notice | $3,400,000 | $0 | $3,400,000 | 12 | Nov 29, 2022 | sec.gov |
| Feb 12, 2021 | New notice | $4,000,000 | $400,000 | $3,600,000 | 4 | Jan 28, 2021 | sec.gov |
| May 29, 2019 | New notice | $184,950 | $184,950 | $0 | 36 | Apr 29, 2019 | sec.gov |
| Oct 9, 2018 | New notice | $1,225,000 | $1,225,000 | $0 | 4 | Sep 24, 2018 | sec.gov |
| Dec 30, 2015 | New notice | $11,060,414 | $95,000 | $10,965,414 | 1 | Dec 15, 2015 | sec.gov |
| Oct 13, 2015 | New notice | $750,000 | $515,700 | $234,300 | 38 | Sep 24, 2015 | sec.gov |
| Jul 9, 2010 | New notice | $175,000 | $175,000 | $0 | 2 | Jul 2, 2010 | sec.gov |
| Jun 15, 2010 | New notice | $10,000 | $10,000 | $0 | 1 | Jun 8, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Andrew W. Kucharchuk | Director | |
| Matthew W. Schwartz, MD | Director | |
| Mick Ruxin | Executive Officer, Director | |
| Jeffrey Busch | Director | |
| Danica Holley | Director | |
| Yvonne Fors | Director | |
| Thomas W. Chilcott | Executive Officer |
Other biotechnology companies in Colorado that filed recently
- HealthVest Fund V LLC offering · Nov 5, 2026
- GelSana Therapeutics, Inc. $4.4 million · Oct 8, 2026
- Renovare Therapeutics, Inc. $100,000 · Oct 2, 2026
- EnteroTrack, LLC $2 million · Sep 25, 2026
Every Form D from the week of Dec 12, 2022 · All recent filings in Colorado · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what THERALINK TECHNOLOGIES, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.